Pulse Biosciences, Inc
PLSE Healthcare Medical Instruments & Supplies
Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.
- Revenue
- +359.3%
- EPS
- −10.3%
- Free cash flow
- −1,180.5%
Quarter to September 2026, against a year earlier
Follow PLSE
Alert me
Pulse Biosciences, Inc (PLSE) Book value per share
Pulse Biosciences, Inc's book value per share at the end of fiscal 2025 was 1.2×, down 39.2% from 2.0× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 2.6×. Over the past ten years it has ranged from −0.1× (fiscal 2022) to 3.9× (fiscal 2018); the current reading is higher than 36% of that period. Pulse Biosciences, Inc ranks 35th of 52 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 1.2× | (39.15%) |
| FY2024 | 2.0× | 120.53% |
| FY2023 | 0.9× | — |
| FY2022 | −0.1× | — |
| FY2021 | 1.3× | 29.60% |
| FY2020 | 1.0× | (33.53%) |
| FY2019 | 1.5× | (61.86%) |
| FY2018 | 3.9× | 24.59% |
| FY2017 | 3.1× | 35.67% |
| FY2016 | 2.3× | 27.22% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 2.6× | 77.49% |
| Jun 2026 | 1.4× | 47.48% |
| Mar 2026 | 1.0× | (18.53%) |
| Dec 2025 | 1.2× | (13.00%) |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| ICUI ICU Medical, Inc. compare | 87.6× |
| TFX Teleflex Incorporated compare | 66.7× |
| MMSI Merit Medical Systems, Inc. compare | 29.2× |
| NVST Envista Holdings Corporation compare | 19.2× |
| MMED MiniMed Group, Inc. compare | 12.9× |
| ATRC AtriCure, Inc. compare | 10.9× |
| STVN Stevanato Group S.p.A. compare | 6.7× |
| WRBY Warby Parker Inc. compare | 3.2× |
| PLSE Pulse Biosciences, Inc | 2.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on PLSE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Altman Z-score
- The full statement